Skip to main content

Articles

Page 63 of 108

  1. Mammographic density is known to be a strong risk factor for breast cancer. A particularly strong association with risk has been observed when density is measured using interactive threshold software. This, ho...

    Authors: Stephen W Duffy, Iris D Nagtegaal, Susan M Astley, Maureen GC Gillan, Magnus A McGee, Caroline RM Boggis, Mary Wilson, Ursula M Beetles, Miriam A Griffiths, Anil K Jain, Jill Johnson, Rita Roberts, Heather Deans, Karen A Duncan, Geeta Iyengar, Pam M Griffiths…
    Citation: Breast Cancer Research 2008 10:R64
  2. The concept of cancer stem cells responsible for tumour origin, maintenance, and resistance to treatment has gained prominence in the field of breast cancer research. The therapeutic targeting of these cells h...

    Authors: Brian J Morrison, Chris W Schmidt, Sunil R Lakhani, Brent A Reynolds and J Alejandro Lopez
    Citation: Breast Cancer Research 2008 10:210
  3. Preoperative chemotherapy is often used in patients with locally advanced breast cancer. However, commonly used clinical and pathological parameters are poor predictors of response to this type of therapy. Rec...

    Authors: Shirly Davidovich, Ofer Ben-Izhak, Ma'anit Shapira, Boris Futerman and Dan D Hershko
    Citation: Breast Cancer Research 2008 10:R63
  4. Breast cancer metastasis is a complex, multi-step biological process. Genetic mutations along with epigenetic alterations in the form of DNA methylation patterns and histone modifications contribute to metasta...

    Authors: David I Rodenhiser, Joseph Andrews, Wendy Kennette, Bekim Sadikovic, Ariel Mendlowitz, Alan B Tuck and Ann F Chambers
    Citation: Breast Cancer Research 2008 10:R62
  5. Oxidative stress can modify estrogen receptor (ER) structure and function, including induction of progesterone receptor (PR), altering the biology and clinical behavior of endocrine responsive (ER-positive) br...

    Authors: Christina Yau and Christopher C Benz
    Citation: Breast Cancer Research 2008 10:R61
  6. We performed a retrospective analysis of HER2-overexpressing metastatic breast cancer patients to describe clinical outcomes of those who, despite progression of the disease (PD), maintained trastuzumab for mu...

    Authors: Giuseppe Cancello, Emilia Montagna, Diego D'Agostino, Mario Giuliano, Antonio Giordano, Giuseppe Di Lorenzo, Monica Plaitano, Sabino De Placido and Michele De Laurentiis
    Citation: Breast Cancer Research 2008 10:R60
  7. The cost of genetic testing and the limited knowledge about the BRCA1 and BRCA2 genes in different ethnic groups has limited its availability in medium- and low-resource countries, including Malaysia. In addition...

    Authors: E Thirthagiri, SY Lee, P Kang, DS Lee, GT Toh, S Selamat, S-Y Yoon, NA Mohd Taib, MK Thong, CH Yip and SH Teo
    Citation: Breast Cancer Research 2008 10:R59
  8. ISG15 is an ubiquitin-like molecule that is strongly upregulated by type I interferons as a primary response to diverse microbial and cellular stress stimuli. However, alterations in the ISG15 signalling pathway...

    Authors: Nuran Bektas, Erik Noetzel, Jürgen Veeck, Michael F Press, Glen Kristiansen, Amjad Naami, Arndt Hartmann, Arno Dimmler, Matthias W Beckmann, Ruth Knüchel, Peter A Fasching and Edgar Dahl
    Citation: Breast Cancer Research 2008 10:R58
  9. Obesity has consistently been associated with postmenopausal breast cancer risk. Proteins that are secreted by adipose tissue or are involved in regulating body mass may play a role in breast tumor development.

    Authors: Heather Spencer Feigelson, Lauren R Teras, W Ryan Diver, Weining Tang, Alpa V Patel, Victoria L Stevens, Eugenia E Calle, Michael J Thun and Mark Bouzyk
    Citation: Breast Cancer Research 2008 10:R57
  10. Endocrine-dependent, estrogen receptor positive breast cancer cells proliferate in response to estrogens, synthesized by the cytochrome p450 aromatase enzyme. Letrozole is a potent nonsteroidal aromatase inhib...

    Authors: Joanna Lisztwan, Astrid Pornon, Bin Chen, Shiuan Chen and Dean B Evans
    Citation: Breast Cancer Research 2008 10:R56
  11. Authors: EAM O'Flynn, JC Morel, J Gonzalez, H Purushothaman, D Evans, R Wasan and MJ Michell
    Citation: Breast Cancer Research 2008 10(Suppl 3):P51

    This article is part of a Supplement: Volume 10 Supplement 3

  12. Authors: K Pinker, W Bogner, S Gruber, P Szomolanyi, G Grabner, G Heinz-Peer, T Helbich and S Trattnig
    Citation: Breast Cancer Research 2008 10(Suppl 3):P16

    This article is part of a Supplement: Volume 10 Supplement 3

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions